Fatih Özkadı and Barış Alparslan set out the company's case for competitive, lower-carbon value chains and the capital needed to build them. ANTALYA, Türkiye, Nov....
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer...
SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ -- Shenzhen Media Group's "Telling China's Story: The 'Circle of Friends' of the Global Development Initiative" program has...
SHANGHAI, Dec. 22, 2025 /PRNewswire/ -- OK Biotech Co., Ltd. has been honoured at the International Innovation Awards (IIA) 2025, organized by Enterprise Asia,...